Neither Taro nor Lupin have yet commented on their launch or pricing plans. The lower dose of Xarelto is already facing competition in other markets, including Europe and Canada, with Bayer ...

In 2021, the American College of Chest Physicians released clinical guidelines that suggested reduced dosage of either ...